Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar;11(3):140-50.
doi: 10.1038/nrendo.2014.234. Epub 2015 Jan 6.

Stromal cells and stem cells in clinical bone regeneration

Affiliations
Review

Stromal cells and stem cells in clinical bone regeneration

Warren L Grayson et al. Nat Rev Endocrinol. 2015 Mar.

Abstract

Stem-cell-mediated bone repair has been used in clinical trials for the regeneration of large craniomaxillofacial defects, to slow the process of bone degeneration in patients with osteonecrosis of the femoral head and for prophylactic treatment of distal tibial fractures. Successful regenerative outcomes in these investigations have provided a solid foundation for wider use of stromal cells in skeletal repair therapy. However, employing stromal cells to facilitate or enhance bone repair is far from being adopted into clinical practice. Scientific, technical, practical and regulatory obstacles prevent the widespread therapeutic use of stromal cells. Ironically, one of the major challenges lies in the limited understanding of the mechanisms via which transplanted cells mediate regeneration. Animal models have been used to provide insight, but these models largely fail to reproduce the nuances of human diseases and bone defects. Consequently, the development of targeted approaches to optimize cell-mediated outcomes is difficult. In this Review, we highlight the successes and challenges reported in several clinical trials that involved the use of bone-marrow-derived mesenchymal or adipose-tissue-derived stromal cells. We identify several obstacles blocking the mainstream use of stromal cells to enhance skeletal repair and highlight technological innovations or areas in which novel techniques might be particularly fruitful in continuing to advance the field of skeletal regenerative medicine.

PubMed Disclaimer

Conflict of interest statement

Competing interests

J.M.G. is co-founder, co-owner and Chief Scientific Officer of LaCell, a biotechnology company focusing on the clinical translation of stromal-cell and stem-cell science. The other authors declare no competing interests.

Figures

Figure 1
Figure 1
Generalized clinical approach for stem-cell-based regeneration of large craniofacial bone defects. Adipose-tissue-derived stromal and/or stem cells are mixed with growth factors (such as BMP-2) and combined with mineral blocks in a preshaped titanium mesh, cultured in vivo and transplanted to repair the bone defect (the mandible is shown as an example). Abbreviations: BMP-2, bone morphogenetic protein 2; HIF-1α, hypoxia-inducible factor 1α.

Similar articles

Cited by

References

    1. Raggatt LJ, et al. Fracture healing via periosteal callus formation requires macrophages for both initiation and progression of early endochondral ossification. Am J Pathol. 2014;184:3192–3204. - PubMed
    1. Das A, Segar CE, Hughley BB, Bowers DT, Botchwey EA. The promotion of mandibular defect healing by the targeting of S1P receptors and the recruitment of alternatively activated macrophages. Biomaterials. 2013;34:9853–9862. - PMC - PubMed
    1. Kuroda R, et al. Clinical impact of circulating CD34-positive cells on bone regeneration and healing. Tissue Eng Part B Rev. 2014;20:190–199. - PMC - PubMed
    1. Hutton DL, Grayson WL. Stem cell-based approaches to engineering vascularized bone. Curr Opin Chem Eng. 2014;3:75–82.
    1. Neovius E, Engstrand T. Craniofacial reconstruction with bone and biomaterials: review over the last 11 years. J Plast Reconstr Aesthet Surg. 2010;63:1615–1623. - PubMed

Publication types